Search

Michael H. Wilson

Supervisory Patent Examiner (ID: 15515, Phone: (571)270-3882 , Office: P/1747 )

Most Active Art Unit
1786
Art Unit(s)
1747, 1786, 1794
Total Applications
427
Issued Applications
225
Pending Applications
9
Abandoned Applications
198

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5921543 [patent_doc_number] => 20060240073 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-26 [patent_title] => 'Structure of modulating intraocular pressure on glaucoma' [patent_app_type] => utility [patent_app_number] => 11/471695 [patent_app_country] => US [patent_app_date] => 2006-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5051 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0240/20060240073.pdf [firstpage_image] =>[orig_patent_app_number] => 11471695 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/471695
Structure of modulating intraocular pressure on glaucoma Jun 20, 2006 Abandoned
Array ( [id] => 5237132 [patent_doc_number] => 20070129289 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-07 [patent_title] => 'Deoxo-proline-containing tamandarin and didemnin analogs, dehydro-proline-containing tamandarin and didemnin analogs, and methods of making and using them' [patent_app_type] => utility [patent_app_number] => 11/455937 [patent_app_country] => US [patent_app_date] => 2006-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 18378 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20070129289.pdf [firstpage_image] =>[orig_patent_app_number] => 11455937 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/455937
Deoxo-proline-containing tamandarin and didemnin analogs, dehydro-proline-containing tamandarin and didemnin analogs, and methods of making and using them Jun 19, 2006 Issued
Array ( [id] => 5786440 [patent_doc_number] => 20060205661 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-14 [patent_title] => 'Novel albumin-free factor VIII formulations' [patent_app_type] => utility [patent_app_number] => 11/434634 [patent_app_country] => US [patent_app_date] => 2006-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7433 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0205/20060205661.pdf [firstpage_image] =>[orig_patent_app_number] => 11434634 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/434634
Albumin-free factor VIII formulations May 14, 2006 Issued
Array ( [id] => 5160400 [patent_doc_number] => 20070173444 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-26 [patent_title] => 'PEPTIDES AND COMPOUNDS THAT BIND TO THE IL-5 RECEPTOR' [patent_app_type] => utility [patent_app_number] => 11/381172 [patent_app_country] => US [patent_app_date] => 2006-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 18788 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20070173444.pdf [firstpage_image] =>[orig_patent_app_number] => 11381172 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/381172
Peptides and compounds that bind to the IL-5 receptor May 1, 2006 Issued
Array ( [id] => 344836 [patent_doc_number] => 07498021 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-03-03 [patent_title] => 'Dental products comprising bone growth enhancing peptide' [patent_app_type] => utility [patent_app_number] => 11/379316 [patent_app_country] => US [patent_app_date] => 2006-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 5946 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/498/07498021.pdf [firstpage_image] =>[orig_patent_app_number] => 11379316 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/379316
Dental products comprising bone growth enhancing peptide Apr 18, 2006 Issued
Array ( [id] => 5851742 [patent_doc_number] => 20060234933 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-19 [patent_title] => 'VASOACTIVE INTESTINAL POLYPEPTIDE PHARMACEUTICALS' [patent_app_type] => utility [patent_app_number] => 11/279238 [patent_app_country] => US [patent_app_date] => 2006-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 14044 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20060234933.pdf [firstpage_image] =>[orig_patent_app_number] => 11279238 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/279238
Vasoactive intestinal polypeptide pharmaceuticals Apr 9, 2006 Issued
Array ( [id] => 5875199 [patent_doc_number] => 20060166897 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-27 [patent_title] => 'Novel indazole peptidomimetics as thrombin receptor antagonists' [patent_app_type] => utility [patent_app_number] => 11/393529 [patent_app_country] => US [patent_app_date] => 2006-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10837 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20060166897.pdf [firstpage_image] =>[orig_patent_app_number] => 11393529 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/393529
Indazole peptidomimetics as thrombin receptor antagonists Mar 29, 2006 Issued
Array ( [id] => 5875198 [patent_doc_number] => 20060166896 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-27 [patent_title] => 'Novel indazole peptidomimetics as thrombin receptor antagonists' [patent_app_type] => utility [patent_app_number] => 11/393350 [patent_app_country] => US [patent_app_date] => 2006-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10836 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20060166896.pdf [firstpage_image] =>[orig_patent_app_number] => 11393350 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/393350
Novel indazole peptidomimetics as thrombin receptor antagonists Mar 29, 2006 Abandoned
Array ( [id] => 5672954 [patent_doc_number] => 20060178309 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-10 [patent_title] => 'Method for the crystallization of human serum albumin' [patent_app_type] => utility [patent_app_number] => 11/378727 [patent_app_country] => US [patent_app_date] => 2006-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 19488 [patent_no_of_claims] => 131 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0178/20060178309.pdf [firstpage_image] =>[orig_patent_app_number] => 11378727 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/378727
Method for the crystallization of human serum albumin Mar 16, 2006 Abandoned
Array ( [id] => 5852014 [patent_doc_number] => 20060235205 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-19 [patent_title] => 'Process for preparing porous collagen matrix from connective tissue' [patent_app_type] => utility [patent_app_number] => 11/371323 [patent_app_country] => US [patent_app_date] => 2006-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4460 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20060235205.pdf [firstpage_image] =>[orig_patent_app_number] => 11371323 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/371323
Process for preparing porous collagen matrix from connective tissue Mar 7, 2006 Issued
Array ( [id] => 5913565 [patent_doc_number] => 20060128627 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-15 [patent_title] => 'Human appetite control by glucagon-like peptide receptor binding compounds' [patent_app_type] => utility [patent_app_number] => 11/348148 [patent_app_country] => US [patent_app_date] => 2006-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6840 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20060128627.pdf [firstpage_image] =>[orig_patent_app_number] => 11348148 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/348148
Human appetite control by glucagon-like peptide receptor binding compounds Feb 5, 2006 Abandoned
Array ( [id] => 307446 [patent_doc_number] => 07531512 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-05-12 [patent_title] => 'Method of use of peptide antagonists of zonulin to prevent or delay the onset of diabetes' [patent_app_type] => utility [patent_app_number] => 11/346395 [patent_app_country] => US [patent_app_date] => 2006-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6417 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/531/07531512.pdf [firstpage_image] =>[orig_patent_app_number] => 11346395 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/346395
Method of use of peptide antagonists of zonulin to prevent or delay the onset of diabetes Feb 2, 2006 Issued
Array ( [id] => 5630941 [patent_doc_number] => 20060147409 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-06 [patent_title] => 'Biocompatible crosslinked polymers with visualization agents' [patent_app_type] => utility [patent_app_number] => 11/293892 [patent_app_country] => US [patent_app_date] => 2005-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 18864 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20060147409.pdf [firstpage_image] =>[orig_patent_app_number] => 11293892 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/293892
Biocompatible crosslinked polymers with visualization agents Dec 1, 2005 Issued
Array ( [id] => 185114 [patent_doc_number] => 07648965 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-01-19 [patent_title] => 'Method for fostering bone formation and preservation' [patent_app_type] => utility [patent_app_number] => 11/267987 [patent_app_country] => US [patent_app_date] => 2005-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 13939 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/648/07648965.pdf [firstpage_image] =>[orig_patent_app_number] => 11267987 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/267987
Method for fostering bone formation and preservation Nov 6, 2005 Issued
Array ( [id] => 5716093 [patent_doc_number] => 20060079456 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-13 [patent_title] => 'Vasoactive intestinal polypeptide pharmaceuticals' [patent_app_type] => utility [patent_app_number] => 11/245499 [patent_app_country] => US [patent_app_date] => 2005-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10785 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0079/20060079456.pdf [firstpage_image] =>[orig_patent_app_number] => 11245499 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/245499
Vasoactive intestinal polypeptide pharmaceuticals Oct 6, 2005 Issued
Array ( [id] => 506385 [patent_doc_number] => 07202341 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-04-10 [patent_title] => 'Stabilized hemoglobin solutions' [patent_app_type] => utility [patent_app_number] => 11/231921 [patent_app_country] => US [patent_app_date] => 2005-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 9 [patent_no_of_words] => 11308 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/202/07202341.pdf [firstpage_image] =>[orig_patent_app_number] => 11231921 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/231921
Stabilized hemoglobin solutions Sep 20, 2005 Issued
Array ( [id] => 5596825 [patent_doc_number] => 20060160743 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-20 [patent_title] => 'Peptides that selectively home to heart vasculature and related conjugates and methods' [patent_app_type] => utility [patent_app_number] => 11/222370 [patent_app_country] => US [patent_app_date] => 2005-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 28248 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20060160743.pdf [firstpage_image] =>[orig_patent_app_number] => 11222370 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/222370
Peptides that selectively home to heart vasculature and related conjugates and methods Sep 6, 2005 Issued
Array ( [id] => 5619982 [patent_doc_number] => 20060189516 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-24 [patent_title] => 'Method for producing cross-linked hyaluronic acid-protein bio-composites' [patent_app_type] => utility [patent_app_number] => 11/208596 [patent_app_country] => US [patent_app_date] => 2005-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 13505 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0189/20060189516.pdf [firstpage_image] =>[orig_patent_app_number] => 11208596 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/208596
Method for producing cross-linked hyaluronic acid-protein bio-composites Aug 22, 2005 Abandoned
Array ( [id] => 5807270 [patent_doc_number] => 20060093624 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-04 [patent_title] => 'Botulinum toxin for treating muscle contracture' [patent_app_type] => utility [patent_app_number] => 11/209304 [patent_app_country] => US [patent_app_date] => 2005-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5142 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20060093624.pdf [firstpage_image] =>[orig_patent_app_number] => 11209304 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/209304
Botulinum toxin for treating muscle contracture Aug 21, 2005 Issued
Array ( [id] => 5672063 [patent_doc_number] => 20060177417 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-10 [patent_title] => 'Pharmaceutical formulations for sustained drug delivery' [patent_app_type] => utility [patent_app_number] => 11/205292 [patent_app_country] => US [patent_app_date] => 2005-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6985 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0177/20060177417.pdf [firstpage_image] =>[orig_patent_app_number] => 11205292 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/205292
Pharmaceutical formulations for sustained drug delivery Aug 14, 2005 Abandoned
Menu